Cargando…

Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy

INTRODUCTION: Primary or metastatic urethral tumors are extremely rare. However, treatment strategies differ between primary and metastatic tumors. Therefore, establishing an accurate diagnosis is critically needed for initiating timely and appropriate therapy. CASE PRESENTATION: We describe the cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Shinnosuke, Ishida, Masaru, Arai, Eri, Baba, Yuto, Anno, Tadatsugu, Kobayashi, Hiroaki, Miyazaki, Yasumasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720727/
https://www.ncbi.nlm.nih.gov/pubmed/35005476
http://dx.doi.org/10.1002/iju5.12394
_version_ 1784625184352763904
author Fujiwara, Shinnosuke
Ishida, Masaru
Arai, Eri
Baba, Yuto
Anno, Tadatsugu
Kobayashi, Hiroaki
Miyazaki, Yasumasa
author_facet Fujiwara, Shinnosuke
Ishida, Masaru
Arai, Eri
Baba, Yuto
Anno, Tadatsugu
Kobayashi, Hiroaki
Miyazaki, Yasumasa
author_sort Fujiwara, Shinnosuke
collection PubMed
description INTRODUCTION: Primary or metastatic urethral tumors are extremely rare. However, treatment strategies differ between primary and metastatic tumors. Therefore, establishing an accurate diagnosis is critically needed for initiating timely and appropriate therapy. CASE PRESENTATION: We describe the case of a 79‐year‐old man with prostate cancer treated with radiotherapy and androgen deprivation therapy. He presented with macroscopic hematuria as a symptom of anterior urethral tumor at follow‐up. Endoscopic tumor resection was performed. Hematoxylin and eosin staining showed adenocarcinoma component. Immunohistochemical staining revealed presence of metastatic prostate cancer to the urethra. CONCLUSION: Regarding urethral tumors diagnosis, urologists should consider the possibility of metastasis from prostate cancer and perform immunohistochemical examination for establishing accurate diagnosis. Furthermore, if androgen deprivation therapy fails to suppress symptoms, radiotherapy or urethrectomy might be considered.
format Online
Article
Text
id pubmed-8720727
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87207272022-01-07 Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy Fujiwara, Shinnosuke Ishida, Masaru Arai, Eri Baba, Yuto Anno, Tadatsugu Kobayashi, Hiroaki Miyazaki, Yasumasa IJU Case Rep Case Reports INTRODUCTION: Primary or metastatic urethral tumors are extremely rare. However, treatment strategies differ between primary and metastatic tumors. Therefore, establishing an accurate diagnosis is critically needed for initiating timely and appropriate therapy. CASE PRESENTATION: We describe the case of a 79‐year‐old man with prostate cancer treated with radiotherapy and androgen deprivation therapy. He presented with macroscopic hematuria as a symptom of anterior urethral tumor at follow‐up. Endoscopic tumor resection was performed. Hematoxylin and eosin staining showed adenocarcinoma component. Immunohistochemical staining revealed presence of metastatic prostate cancer to the urethra. CONCLUSION: Regarding urethral tumors diagnosis, urologists should consider the possibility of metastasis from prostate cancer and perform immunohistochemical examination for establishing accurate diagnosis. Furthermore, if androgen deprivation therapy fails to suppress symptoms, radiotherapy or urethrectomy might be considered. John Wiley and Sons Inc. 2021-11-02 /pmc/articles/PMC8720727/ /pubmed/35005476 http://dx.doi.org/10.1002/iju5.12394 Text en © 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Fujiwara, Shinnosuke
Ishida, Masaru
Arai, Eri
Baba, Yuto
Anno, Tadatsugu
Kobayashi, Hiroaki
Miyazaki, Yasumasa
Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title_full Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title_fullStr Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title_full_unstemmed Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title_short Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
title_sort isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720727/
https://www.ncbi.nlm.nih.gov/pubmed/35005476
http://dx.doi.org/10.1002/iju5.12394
work_keys_str_mv AT fujiwarashinnosuke isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT ishidamasaru isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT araieri isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT babayuto isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT annotadatsugu isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT kobayashihiroaki isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy
AT miyazakiyasumasa isolatedrecurrenceofprostatecancertotheanteriorurethra5yearsafterradiationtherapy